TG Therapeutics Inc (TGTX)
Working capital turnover
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 329,004 | 262,359 | 340,582 | 280,254 | 222,343 | 180,883 | 18,875 | 6,331 | 2,784 | 5,025 | 6,961 | 7,912 | 6,689 | 4,406 | 2,414 | 907 | 152 | 152 | 152 | 152 |
Total current assets | US$ in thousands | 566,359 | 574,069 | 389,150 | 360,581 | 317,943 | 319,114 | 208,574 | 184,783 | 168,274 | 182,922 | 202,560 | 242,216 | 330,965 | 371,779 | 455,068 | 535,013 | 611,740 | 260,335 | 280,938 | 88,016 |
Total current liabilities | US$ in thousands | 90,679 | 125,114 | 108,664 | 99,684 | 53,720 | 57,678 | 72,667 | 63,076 | 53,201 | 36,447 | 43,326 | 54,656 | 65,384 | 87,655 | 87,551 | 92,494 | 87,554 | 77,670 | 67,537 | 63,118 |
Working capital turnover | 0.69 | 0.58 | 1.21 | 1.07 | 0.84 | 0.69 | 0.14 | 0.05 | 0.02 | 0.03 | 0.04 | 0.04 | 0.03 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
December 31, 2024 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $329,004K ÷ ($566,359K – $90,679K)
= 0.69
Working capital turnover measures how efficiently a company utilizes its working capital to generate sales revenue. A higher ratio indicates better efficiency in utilizing working capital to generate sales.
For TG Therapeutics Inc, the working capital turnover has shown fluctuations over the quarters. From a low of 0.00 in June 2020, the ratio gradually increased to reach 1.21 by June 2024. This indicates a significant improvement in the efficiency of working capital utilization over the analyzed period.
The company's working capital turnover ratio reached its peak at 1.21 in June 2024, suggesting that TG Therapeutics Inc was able to generate $1.21 in sales for every dollar of working capital invested. This signifies an efficient use of working capital resources to drive revenue growth.
Overall, the trend of increasing working capital turnover ratio indicates that TG Therapeutics Inc has been effectively managing its working capital to support sales growth and enhance operational efficiency.
Peer comparison
Dec 31, 2024